Mercy Medical Center, Des Moines, Iowa Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02102555
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Mercy Medical Center-Des Moines General Surgery Residency

Active Ingredients

Drugs in Phase 3 Trials (1)

acetaminophen (tylenol) (1 trial)

Drugs in Other Trials (4)

magnesium sulfate (Tis-U-Sol) (1 trial)

potassium sulfate (1 trial)

simethicone (IMODIUM) (1 trial)

sodium sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nausea (Phase 3)

Pain, Postoperative (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5